Chief Executive Officer (CEO)
Cyrille Labourel serves as the CEO of ASCEND Therapeutics US, LLC, a role he has held since January 2023. He has over 15 years of leadership and brand marketing experience across the consumer health and pharmaceutical industry. Cyrille has a track record of driving growth and innovation with a strong consumer centric approach. Prior to joining ASCEND, Cyrille spent about 10 years at Johnson and Johnson and more recently was leading Merck/Organon’s contraceptive business. Cyrille is a graduate of Sciences Po in Paris and ESCCA in Angers, France and completed a MBA from the University of Wisconsin.